Cargando…
Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis
BACKGROUND: To explore the activity of pazopanib (P) + sirolimus (S) in patients who progressed after previous clinical benefit on pazopanib. METHODS: Eight patients with progressing metastatic high grade soft tissue sarcoma (STS) whose disease advanced on P following a response duration of at least...
Autores principales: | Katz, D., Azraq, Y., Eleyan, F., Gill, S., Peretz, T., Merimsky, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977830/ https://www.ncbi.nlm.nih.gov/pubmed/27501793 http://dx.doi.org/10.1186/s12885-016-2618-1 |
Ejemplares similares
-
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial
por: Jones, Robin L., et al.
Publicado: (2022) -
Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019) -
Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010) -
Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017) -
Phototoxic Reaction Induced by Pazopanib
por: Udompanich, Siriorn, et al.
Publicado: (2018)